{
  "2023": [
    {
      "title": "CRISPR therapy wins global approval",
      "description": "Regulators move to approve the first CRISPR‑based gene‑editing therapies, marking the shift of gene editing into real‑world clinical practice.",
      "url": "https://www.nature.com/articles/d41586-023-03685-9",
      "morelink": "Nature"
    },
    {
      "title": "AI expands in biotech drug discovery",
      "description": "AI algorithms increasingly powered genomic analysis and compound screening, with platforms like DeepMind’s AlphaFold accelerating molecular research.",
      "url": "https://www.deepmind.com/research/highlighted-research/alphafold",
      "morelink": "DeepMind"
    },
    {
      "title": "Synthetic biology drives lab-grown meat scale-up",
      "description": "Companies like Upside Foods and Eat Just advanced FDA clearance for cultivated meat, thanks to CRISPR and fermentation innovation.",
      "url": "https://www.foodingredientsfirst.com/news/a-new-era-upside-foods-and-good-meat-receive-landmark-regulatory-clearance-for-us-cultivated-chicken-sales.html",
      "morelink": "Food Navigator"
    },
    {
      "title": "3D bioprinting matures",
      "description": "Biomaterials and 3D‑bioprinting techniques are advancing from preclinical scaffolds toward regulatory‑stage tissue engineering and organ‑repair prototypes",
      "url": "https://www.labiotech.eu/in-depth/biomaterial-tissue-engineering/",
      "morelink": "Labiotech"
    },
    {
      "title": "Agri-biotech enhances crop resilience",
      "description": "Gene-edited and drought-resistant crops were commercialized in 2023 to address food security and climate adaptation.",
      "url": "https://www.agtechnavigator.com/Article/2023/12/20/Scientists-hope-to-feed-the-world-with-climate-resilient-crops/",
      "morelink": "Nature"
    }
  ]
}
